Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.
Lancet
; 369(9564): 836-843, 2007 Mar 10.
Article
in En
| MEDLINE
| ID: mdl-17350452
Full text:
1
Database:
MEDLINE
Main subject:
Protein C
/
Sepsis
/
Anti-Infective Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Newborn
Language:
En
Year:
2007
Type:
Article